Cannabinoid Pharmacology - 1st Edition - ISBN: 9780128112328, 9780128112335

Cannabinoid Pharmacology, Volume 80

1st Edition

Serial Volume Editors: David Kendall Stephen Alexander
eBook ISBN: 9780128112335
Hardcover ISBN: 9780128112328
Imprint: Academic Press
Published Date: 24th August 2017
Page Count: 492
Tax/VAT will be calculated at check-out Price includes VAT (GST)
15% off
15% off
183.00
155.55
155.00
131.75
256.00
Unavailable
Price includes VAT (GST)
× DRM-Free

Easy - Download and start reading immediately. There’s no activation process to access eBooks; all eBooks are fully searchable, and enabled for copying, pasting, and printing.

Flexible - Read on multiple operating systems and devices. Easily read eBooks on smart phones, computers, or any eBook readers, including Kindle.

Open - Buy once, receive and download all available eBook formats, including PDF, EPUB, and Mobi (for Kindle).

Institutional Access

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

1. Endocannabinoids and their congeners

  Fabiana Piscitelli

2. Endocannabinoid turnover

  Steve P.H Alexander

3. Plant cannabinoids

  Ethan Russo

4. Synthetic cannabinoids and ‘legal highs’

  Paco Molina-Holgado

5. CB1 and CB2 cannabinoid receptors

  Mary Abood

6. Novel signalling modalities

  Dave Kendall

7. Novel cannabinoid receptors

  Andy Irving

8. Ion channel regulation by cannabinoids

  Alessia Ligresti

9. Nuclear hormone receptors responding to cannabinoids

  Saoirse O’Sullivan

10. The cardiovascular system

  Vanessa Ho

11. Metabolism and feeding

  Jocelijn Meijerink

12. Immune regulation

  Scott Graham

13. Cancer

  Burkhard Hinz

14. CNS: pain pathways

  David Finn


Description

Cannabinoid Pharmacology, Volume 80 is a new volume in the Advances in Pharmacology that presents reviews of recent breakthroughs. This volume aims to present current knowledge of the endogenous cannabinoid system, and looks at molecular, cellular, tissue and organismal effects of endogenous and exogenous cannabinoids. Topics of note in this new volume include Endocannabinoids and their congeners, Endocannabinoid turnover, Plant cannabinoids, Synthetic cannabinoids and ‘legal highs’, CB1 and CB2 cannabinoid receptors, Novel signaling modalities, Novel cannabinoid receptors, and Ion channel regulation by cannabinoids.

There is a broad coverage of the essential elements associated with the cannabinoid system. The Editors have sought to include authors who represent authoritative voices on these themes, but have not previously worked together to allow a fresh approach to the individual aspects covered.

Key Features

  • Presents reviews of recent breakthroughs in the cannabinoid system
  • Features chapters from the best authors in the field
  • Provides an essential resource for scientists, advanced undergraduate students through to established faculty members

Readership

Scientists seeking to establish or enhance their knowledge of the cannabinoid system. This would include advanced undergraduate students through to established faculty members, making their first attempts at understanding the topic


Details

No. of pages:
492
Copyright:
© Academic Press 2017
Published:
Imprint:
Academic Press
eBook ISBN:
9780128112335
Hardcover ISBN:
9780128112328

About the Serial Volume Editors

David Kendall Serial Volume Editor

David Kendall has had an active interest in cannabinoid research for over 20 years focussing initially on endocannabinoid signalling in the vascular system and latterly in its roles in pain. He was Professor of Pharmacology in the University of Nottingham Medical School until 2015 before taking up the position of Chief Scientific Officer for the drug discovery company PharmNovo.

Affiliations and Expertise

Nottingham University, Nottingham, UK

Stephen Alexander Serial Volume Editor

Dr Stephen Alexander has been interested in the regulation of mammalian cannabinoid systems since the first identification of an endogenous cannabinoid molecule in 1993. He has principally focused on the enzymes associated with the hydrolysis and transformation of these endocannabinoids, both in terms of establishing high throughput assays for these enzymes and also in quantifying their activities in tissues ex vivo. He is an Associate Professor of Molecular Pharmacology at the University of Nottingham, Chair of the Nomenclature Committee of the International Union of Basic and Clinical Pharmacology and has been President of the International Cannabinoid Research Society.

Affiliations and Expertise

University of Nottingham Medical School, Nottingham, UK